Stepan Company filings document the regulatory record for a specialty and intermediate chemicals manufacturer whose common stock trades on the New York Stock Exchange under symbol SCL. Its 8-K filings report operating results, dividend declarations, material-event disclosures, capital-structure information and exit or disposal activities tied to manufacturing and efficiency initiatives.
Stepan proxy and annual-meeting filings cover director elections, advisory compensation votes, auditor ratification, executive compensation governance and benefit-plan matters. The filing record also includes disclosure on restructuring charges, asset write-downs, decommissioning costs and other governance or financial matters reported through current reports and proxy materials.
STEPAN CO President & CEO Luis Rojo reported equity award activity involving restricted stock units and common shares. On the reported date, 683 restricted stock units were exercised and settled into 683 shares of common stock at $66.3900 per share. To cover tax obligations, 237 common shares were disposed of through a tax-withholding transaction, leaving 15,640.901 common shares held directly after these transactions. An additional 511.8300 common shares are held indirectly through the Esop II Trust. The filing also amends a prior report to correct the dates for “Date Exercisable” and “Expiration Date” on the related award.
STEPAN CO executive Richard Finn, Vice President and General Manager of Polymers, reported equity award activity in company stock. On February 17, 2026, 341 restricted stock units were exercised and settled into 341 shares of common stock at $66.39 per share, consistent with the award terms.
To cover taxes on the RSU vesting, 118 shares of common stock were withheld, also at $66.39 per share. After these transactions, Finn directly held 241,339.15 shares of common stock. He also reported indirect holdings, including 43,439 shares held by a daughter, 5,174 by a spouse, 95,416 by a trust, and 1,238.22 by an ESOP II trust.
Stepan Company executive Sean Thomas Moriarty reported equity award activity involving restricted stock units and common stock. On February 17, 2026, 455 restricted stock units were exercised into 455 shares of Stepan common stock at a stated price of $66.39 per share, consistent with an exercise or conversion of derivative securities. To cover tax obligations on the RSU vesting, 158 common shares were disposed of through share withholding, rather than an open-market sale. After these transactions, Moriarty directly holds 14,145.4635 shares of Stepan common stock and indirectly holds 4,478.3510 shares through the ESOP II Trust.
Stepan Company’s President and CEO Luis Rojo reported equity award activity involving restricted stock units and common shares. On February 17, 2026, 683 restricted stock units were settled into 683 shares of common stock, consistent with the award terms where each unit equals one share.
To cover tax obligations related to this settlement, 237 restricted stock units were disposed of at a price of $66.39 per share. Following these transactions, Rojo directly owns 795 restricted stock units and 15,877.901 shares of common stock, plus an additional 511.83 shares held indirectly through the ESOP II Trust.
STEPAN CO director Quinn Stepan Jr. reported an indirect transaction involving share units tied to a deferred compensation arrangement rather than open-market trading. On February 9, 2026, 7,517.35 Share Units, each economically equivalent to one share of common stock, were involved in an exercise or conversion of a derivative security under the Management Incentive Plan, a nonqualified deferred compensation plan. According to the footnotes, these share units were settled in cash, and the holdings are reported as indirect, including amounts held through a father's deferred MIP and an estate for which he serves as executor. After the transaction, indirect holdings related to this arrangement totaled 35,649.518 Share Units.
Dimensional Fund Advisors LP filed an amended Schedule 13G reporting that it may be deemed to beneficially own 1,123,035 shares of Stepan Co common stock, representing 5.0% of the class as of the event date. Dimensional has sole power to vote 1,090,399 shares and sole power to dispose of 1,123,035 shares. The shares are owned by various investment funds and accounts it advises (the “Funds”), and Dimensional disclaims beneficial ownership, stating the securities are held in the ordinary course of business and not for the purpose of changing or influencing control of Stepan Co.
Stepan Company director F. Quinn Stepan Jr. reported exercising 34,741 employee stock options on January 13, 2026 at an exercise price of $43.85 per share. The options converted into the same number of Stepan common shares in an exercise-and-hold transaction, leaving him with 160,960.262 common shares held directly.
In addition to these directly held shares, the filing lists various indirect holdings of Stepan common stock through entities such as a family LLC, several family trusts, an ESOP trust, and accounts associated with his spouse and other family members. For certain of these positions, he disclaims beneficial ownership except to the extent of any pecuniary interest, and some shares are held in estates or plans where he serves in an administrative role.
Stepan Company insider Luis Rojo, who serves as President & CEO and a director of Stepan Company, reported routine equity compensation activity. On 12/31/2025, restricted stock units (RSUs) covering 4,202 shares were settled in Stepan common stock at a price of $47.205 per share, consistent with the award terms. Each RSU represents a right to receive one share of Stepan common stock.
To cover tax obligations arising from the RSU vesting, 1,232 RSUs were withheld at a price of $47.205 per share. Following these transactions, Rojo beneficially owned 15,194.901 shares of Stepan common stock directly, 511.83 shares indirectly through the Esop II Trust, and continued to hold 7,175 RSUs and other derivative equity interests.
Stepan Company executive Robert Haire reported equity award activity involving Stepan Co. (SCL) common stock. On 12/31/2025, restricted stock units (RSUs) were settled in shares of common stock, resulting in the acquisition of 1,891 shares at a price of $47.205 per share. After this transaction, Haire beneficially owned 2,482 shares of common stock directly and 90.269 shares indirectly through an ESOP II Trust.
In connection with the RSU vesting, 574 RSUs were withheld to satisfy tax liabilities, leaving 1,318 RSUs beneficially owned following the reported transactions. Each RSU represents a contingent right to receive one share of Stepan Company common stock, and these RSUs vest ratably over two years beginning on the date shown.
Stepan Co director reports an insider stock transaction. A director of Stepan Co (ticker SCL) filed a Form 4 for a transaction dated 12/23/2025. The filing shows a gift transaction (code G) of 95.858 shares of Stepan common stock at a stated price of $0, reflecting a transfer without consideration. After this transaction, the director directly beneficially owns 126,219.262 shares of Stepan common stock.
The report also lists extensive indirect holdings in Stepan common stock through various vehicles, including an ESOP II trust, multiple family limited liability companies and family trusts, a spouse, a father, and an estate, with certain interests expressly disclaimed except to the extent of any pecuniary interest.